Submitted by Anonymous (not verified) on 22 October 2025 - 10:48
Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Date of authorisation: 19/09/2022, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tezspire, tezepelumab, Date of authorisation: 19/09/2022, Revision: 13, Status: Authorised